July 2011

WEBINAR: “Enhancing adolescent HIV care” with Ruby Fayorsey, MD; Stephen Arpadi, MD, MS, Beatriz Thome, August 18, 2011, 9:00am ET

WEBINAR: "Rapid initiation of ART/ARV during pregnancy” wth Elaine Abrams, MD, September 15, 2011, 9:00am ET

WEBINAR: “Methods for addressing implementation research questions: experiences from ICAP studies” with Harriet Nuwagaba-Biribonwoha, MD, PhD, September 22, 2011, 9:00 am ET

WEBINAR: “Basic epidemiologic measures of disease occurrence” with Bill Reidy, PhD, October 13, 2011, 9:00 am ET

ICAP Participates in Nelson Mandela Day
ICAP's office in South Africa celebrated Mandela Day on July 18 by participating in HIV awareness activities in the  "Bikers for Nelson Mandela” Project.  Accompanying a group of South Africans who rode motorcycles across the country to share the message of making the world a better place, HIV information sessions were conducted along the route at the various Mandela Day projects. More on Nelson Mandela Day

ABOUT ICAP
ICAP was founded in 2004 at Columbia University’s Mailman School of Public Health. Now a global leader in HIV/AIDS services, ICAP has supported work at more than 1,200 sites across 21 countries. More than one million people have received HIV services through ICAP-supported programs.

For more information about ICAP, visit here. For more information about ICAP leadership, visit here.

Supported by Doris Duke Charitable Foundation, Bill and Melinda Gates Foundation, William and Flora Hewlett Foundation, Robert Wood Johnson Foundation, Henry J. Kaiser Family Foundation, Stephen Lewis Foundation, John D. and Catherine T. MacArthur Foundation, National Institutes of Health, David and Lucille Packard Foundation, Rockefeller Foundation, and Starr Foundation.


© 2011 ICAP

Contact US | Unsubscribe

Follow ICAP on Facebook  

Launch of JAIDS Supplement “Bridging the Divide”

The ICAP-sponsored August 2011 Journal of Acquired Immune Deficiency Syndromes (JAIDS) Supplement entitled "Bridging the Divide" was launched at the IAS Conference in Rome.  Wafaa El-Sadr, ICAP Director, Miriam Rabkin, ICAP Director for Health Systems Strategies, Rifat Atun from the Global Fund, and Kevin DeCock from the Global Health Center at the CDC served as guest editors. The supplement contains 5 articles with ICAP co-editors.

As the editors note in the Supplement introduction, the $15 billion invested over less than a decade has led to a dramatic increase in access to HIV prevention, care, and treatment services in low- and middle-income countries. Over five million people are now receiving antiretroviral therapy (ART) in low- and middle-income countries, “a number that would have seemed like an impossible dream at the turn of the century when only about 100,000 had access to these lifesaving medications.” Although much remains to be done—ART coverage is still only about 30 percent in sub-Saharan Africa—the scale-up of ART has also made possible the provision of complex continuity care to some of the world's poorest communities. “More than this, these achievements have changed the way we think about global health.”

El-Sadr et al. point to the fact that there are a multitude of “divides” in the field of global health, including the divide between interest in HIV services versus interest in maternal and child health (MCH), non-communicable diseases, or other specific health conditions, the divide between expertise in HIV programming versus expertise in health systems and economics, and the divide between policy makers concerned with reaching the Millennium Development Goals versus those focused on achievement of HIV-related targets. The recognition of the profound impact of these divides and the potential benefits in overcoming them and working together towards mutual goals motivated this Supplement.

El-Sadr et al. note that, “We need to bridge the divides that separate us to ensure constructive debates that move us forward in the fight against HIV and toward confronting other health threats...Through efforts, such as the ones advanced by the authors in this Supplement, we can effectively bridge the divides to foster collaboration, and gain deeper insights, that will enable us to achieve expanded access to lifesaving interventions and improved health outcomes for all.”

View the full JAIDS Supplement

ICAP interviewed one of the authors, Margaret Kruk of the Mailman School of Public Health, on her article for the Supplement, "Bridging the Divide."

 

ICAP Joins Global Community at IAS 2011 in Rome

One of the highlights of ICAP-supported activities at IAS 2011 was a pre-conference meeting on HIV and Non Communicable Diseases (NCDs).  The meeting was sponsored by ICAP in collaboration with the International AIDS Society, The Global Fund to Fight AIDS, Tuberculosis and Malaria, the French National Agency for Research on AIDS and Viral Hepatitis (ANRS), the U.S. National Institutes of Health (NIH), the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), and the NCD Alliance.
              
A central focus of the meeting was fostering interdisciplinary partnerships between HIV experts, NCD experts, policy makers, health economists, and health systems experts—an objective that has been underscored as a critical step to addressing the emerging importance of NCDs and the continuing challenge of the HIV epidemic.  Additionally, conference participants sought practical lessons to leverage HIV scale-up to address the prevention and management of NCDs such as diabetes, cardiovascular disease, cancers, chronic respiratory diseases, and mental health. Conversely, research findings on metabolic disorders and emerging risk for NCDs amongst individuals with HIV were also reviewed and strategies discussed to address these through HIV programming.  

Other presentations included one by El-Sadr at a special session at the IAS Conference. In a presentation entitled “From Evidence to Action: Challenges and Opportunities” she placed the groundbreaking trial results from the HPTN 052 study into perspective by discussing how to incorporate these findings into programs.  The trial demonstrated that starting ART in HIV-infected individuals substantially protected their HIV-uninfected sexual partners from acquiring HIV infection.

ICAP Senior Research Director Elaine Abrams moderated a panel that addressed the current and future pipeline of pediatric formulations, such as fixed-dose combinations (FDCs) in a satellite session presentation, “Challenges in the Development and Procurement of Pediatric ARV Formulations.”

Other presentations by ICAP supported work included strengthening of health systems for chronic care and noncommunicable diseases in Ethiopia; the role of primary health facilities in expanding pediatric care and treatment services in sub-Saharan Africa; and risk factors for loss to follow-up prior to ART initiation among HIV patients.

View slides, webcasts, and photos from the IAS 2011 Conference

Interactive: ICAP in Nigeria